Literature DB >> 15226133

Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women.

Judith A Cook1, Dennis Grey, Jane Burke, Mardge H Cohen, Alejandra C Gurtman, Jean L Richardson, Tracey E Wilson, Mary A Young, Nancy A Hessol.   

Abstract

OBJECTIVES: We examined associations between depressive symptoms and AIDS-related mortality after controlling for antiretroviral therapy use, mental health treatment, medication adherence, substance abuse, clinical indicators, and demographic factors.
METHODS: One thousand seven hundred sixteen HIV-seropositive women completed semiannual visits from 1994 through 2001 to clinics at 6 sites. Multivariate Cox and logistic regression analyses estimated time to AIDS-related death and depressive symptom severity.
RESULTS: After we controlled for all other factors, AIDS-related deaths were more likely among women with chronic depressive symptoms, and symptoms were more severe among women in the terminal phase of their illness. Mental health service use was associated with reduced mortality.
CONCLUSIONS: Treatment for depression is a critically important component of comprehensive care for HIV-seropositive women, especially those with end-stage disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226133      PMCID: PMC1448411          DOI: 10.2105/ajph.94.7.1133

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  20 in total

1.  Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.

Authors:  V Gordillo; J del Amo; V Soriano; J González-Lahoz
Journal:  AIDS       Date:  1999-09-10       Impact factor: 4.177

2.  Disease progression in HIV-positive women with moderate to severe immunosuppression: the role of depression. Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders.

Authors:  K Vedhara; G Schifitto; M McDermott
Journal:  Behav Med       Date:  1999       Impact factor: 3.104

Review 3.  Neuroendocrine-immune interactions.

Authors:  S Reichlin
Journal:  N Engl J Med       Date:  1993-10-21       Impact factor: 91.245

4.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

5.  Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women.

Authors:  Judith A Cook; Mardge H Cohen; Jane Burke; Dennis Grey; Kathryn Anastos; Lynn Kirstein; Herminia Palacio; Jean Richardson; Tracey Wilson; Mary Young
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-01       Impact factor: 3.731

6.  Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.

Authors:  Mardge H Cohen; Audrey L French; Lorie Benning; Andrea Kovacs; Kathryn Anastos; Mary Young; Howard Minkoff; Nancy A Hessol
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

7.  Depressive symptoms, major depression, and generalized anxiety: a comparison of self-reports on CES-D and results from diagnostic interviews.

Authors:  N Breslau
Journal:  Psychiatry Res       Date:  1985-07       Impact factor: 3.222

Review 8.  Depression and immunity: a meta-analytic review.

Authors:  T B Herbert; S Cohen
Journal:  Psychol Bull       Date:  1993-05       Impact factor: 17.737

9.  Depression and mortality in nursing homes.

Authors:  B W Rovner; P S German; L J Brant; R Clark; L Burton; M F Folstein
Journal:  JAMA       Date:  1991-02-27       Impact factor: 56.272

10.  Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study.

Authors:  C G Lyketsos; D R Hoover; M Guccione; W Senterfitt; M A Dew; J Wesch; M J VanRaden; G J Treisman; H Morgenstern
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

View more
  143 in total

1.  Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial.

Authors:  Alexander C Tsai; Dan H Karasic; Gwendolyn P Hammer; Edwin D Charlebois; Kathy Ragland; Andrew R Moss; James L Sorensen; James W Dilley; David R Bangsberg
Journal:  Am J Public Health       Date:  2012-06-21       Impact factor: 9.308

2.  Selective neurocognitive deficits and poor life functioning are associated with significant depressive symptoms in alcoholism-HIV infection comorbidity.

Authors:  Stephanie A Sassoon; Margaret J Rosenbloom; Rosemary Fama; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Psychiatry Res       Date:  2012-05-29       Impact factor: 3.222

3.  Menstrual cycle phase and single tablet antiretroviral medication adherence in women with HIV.

Authors:  Nancy A Hessol; Susan Holman; Howard Minkoff; Mardge H Cohen; Elizabeth T Golub; Seble Kassaye; Roksana Karim; Oluwakemi Sosanya; Christopher Shaheen; Zaher Merhi
Journal:  AIDS Care       Date:  2015-08-14

4.  Violent Victimization, Mental Health, and Service Utilization Outcomes in a Cohort of Homeless and Unstably Housed Women Living With or at Risk of Becoming Infected With HIV.

Authors:  Alexander C Tsai; Sheri D Weiser; Samantha E Dilworth; Martha Shumway; Elise D Riley
Journal:  Am J Epidemiol       Date:  2015-03-31       Impact factor: 4.897

5.  The adoption of mental health drugs on state AIDS drug assistance program formularies.

Authors:  Erika G Martin; Colleen L Barry
Journal:  Am J Public Health       Date:  2011-04-14       Impact factor: 9.308

6.  Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV.

Authors:  Joseph A Delaney; Robin M Nance; Bridget M Whitney; Frederick L Altice; Xinyuan Dong; Maria Esther Perez Trejo; Mika Matsuzaki; Faye S Taxman; Geetanjali Chander; Irene Kuo; Rob Fredericksen; Lauren N Strand; Joseph J Eron; Elvin Geng; Mari M Kitahata; William C Mathews; Kenneth Mayer; Richard D Moore; Michael S Saag; Sandra Springer; Redonna Chandler; Shoshana Kahana; Heidi M Crane
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

7.  A Cross-Sectional Study of Depressive Symptoms and Risky Alcohol Use Behaviors Among HIV Primary Care Patients in New York City.

Authors:  Yasemin Algur; Jennifer C Elliott; Efrat Aharonovich; Deborah S Hasin
Journal:  AIDS Behav       Date:  2018-05

8.  Open-label, randomized, parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects.

Authors:  Russell E Poland; Lev Gertsik; Joya T Favreau; Shawnee I Smith; James M Mirocha; Uma Rao; Eric S Daar
Journal:  J Altern Complement Med       Date:  2012-10-25       Impact factor: 2.579

9.  Prevalence and predictors of posttraumatic stress disorder and depression in HIV-infected and at-risk Rwandan women.

Authors:  Mardge H Cohen; Mary Fabri; Xiaotao Cai; Qiuhu Shi; Donald R Hoover; Agnes Binagwaho; Melissa A Culhane; Henriette Mukanyonga; Davis Ksahaka Karegeya; Kathryn Anastos
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

10.  Depressive Symptoms at HIV Testing and Two-Year All-Cause Mortality Among Men Who Inject Drugs in Vietnam.

Authors:  Sara N Levintow; Brian W Pence; Tran Viet Ha; Nguyen Le Minh; Teerada Sripaipan; Carl A Latkin; Pham The Vu; Vu Minh Quan; Constantine Frangakis; Vivian F Go
Journal:  AIDS Behav       Date:  2019-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.